196 related articles for article (PubMed ID: 38309262)
1. Regulation of inositol 5-phosphatase activity by the C2 domain of SHIP1 and SHIP2.
Bradshaw WJ; Kennedy EC; Moreira T; Smith LA; Chalk R; Katis VL; Benesch JLP; Brennan PE; Murphy EJ; Gileadi O
Structure; 2024 Apr; 32(4):453-466.e6. PubMed ID: 38309262
[TBL] [Abstract][Full Text] [Related]
2. The SH2 domains of inositol polyphosphate 5-phosphatases SHIP1 and SHIP2 have similar ligand specificity but different binding kinetics.
Zhang Y; Wavreille AS; Kunys AR; Pei D
Biochemistry; 2009 Nov; 48(46):11075-83. PubMed ID: 19839650
[TBL] [Abstract][Full Text] [Related]
3. A novel SH2-containing phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase (SHIP2) is constitutively tyrosine phosphorylated and associated with src homologous and collagen gene (SHC) in chronic myelogenous leukemia progenitor cells.
Wisniewski D; Strife A; Swendeman S; Erdjument-Bromage H; Geromanos S; Kavanaugh WM; Tempst P; Clarkson B
Blood; 1999 Apr; 93(8):2707-20. PubMed ID: 10194451
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic potential of SH2 domain-containing inositol-5'-phosphatase 1 (SHIP1) and SHIP2 inhibition in cancer.
Fuhler GM; Brooks R; Toms B; Iyer S; Gengo EA; Park MY; Gumbleton M; Viernes DR; Chisholm JD; Kerr WG
Mol Med; 2012 Feb; 18(1):65-75. PubMed ID: 22033675
[TBL] [Abstract][Full Text] [Related]
5. SH2-containing inositol 5-phosphatases 1 and 2 in blood platelets: their interactions and roles in the control of phosphatidylinositol 3,4,5-trisphosphate levels.
Giuriato S; Pesesse X; Bodin S; Sasaki T; Viala C; Marion E; Penninger J; Schurmans S; Erneux C; Payrastre B
Biochem J; 2003 Nov; 376(Pt 1):199-207. PubMed ID: 12885297
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms controlling membrane recruitment and activation of the autoinhibited SHIP1 inositol 5-phosphatase.
Waddell GL; Drew EE; Rupp HP; Hansen SD
J Biol Chem; 2023 Aug; 299(8):105022. PubMed ID: 37423304
[TBL] [Abstract][Full Text] [Related]
7. The SH2 domain containing inositol 5-phosphatase SHIP2 displays phosphatidylinositol 3,4,5-trisphosphate and inositol 1,3,4,5-tetrakisphosphate 5-phosphatase activity.
Pesesse X; Moreau C; Drayer AL; Woscholski R; Parker P; Erneux C
FEBS Lett; 1998 Oct; 437(3):301-3. PubMed ID: 9824312
[TBL] [Abstract][Full Text] [Related]
8. The two SH2-domain-containing inositol 5-phosphatases SHIP1 and SHIP2 are coexpressed in human T lymphocytes.
Bruyns C; Pesesse X; Moreau C; Blero D; Erneux C
Biol Chem; 1999; 380(7-8):969-74. PubMed ID: 10494849
[TBL] [Abstract][Full Text] [Related]
9. Regulation of the Src homology 2 domain-containing inositol 5'-phosphatase (SHIP1) by the cyclic AMP-dependent protein kinase.
Zhang J; Walk SF; Ravichandran KS; Garrison JC
J Biol Chem; 2009 Jul; 284(30):20070-8. PubMed ID: 19494109
[TBL] [Abstract][Full Text] [Related]
10. The termination of PI3K signalling by SHIP1 and SHIP2 inositol 5-phosphatases.
Backers K; Blero D; Paternotte N; Zhang J; Erneux C
Adv Enzyme Regul; 2003; 43():15-28. PubMed ID: 12791379
[No Abstract] [Full Text] [Related]
11. SHIP1 and its role for innate immune regulation-Novel targets for immunotherapy.
Yeoh WJ; Krebs P
Eur J Immunol; 2023 Dec; 53(12):e2350446. PubMed ID: 37742135
[TBL] [Abstract][Full Text] [Related]
12. The mouse SHIP2 (Inppl1) gene: complementary DNA, genomic structure, promoter analysis, and gene expression in the embryo and adult mouse.
Schurmans S; Carrió R; Behrends J; Pouillon V; Merino J; Clément S
Genomics; 1999 Dec; 62(2):260-71. PubMed ID: 10610720
[TBL] [Abstract][Full Text] [Related]
13. Characterization of the substrate specificity of the inositol 5-phosphatase SHIP1.
Nelson N; Wundenberg T; Lin H; Rehbach C; Horn S; Windhorst S; Jücker M
Biochem Biophys Res Commun; 2020 Apr; 524(2):366-370. PubMed ID: 32005521
[TBL] [Abstract][Full Text] [Related]
14. The association between the SH2-containing inositol polyphosphate 5-Phosphatase 2 (SHIP2) and the adaptor protein APS has an impact on biochemical properties of both partners.
Onnockx S; De Schutter J; Blockmans M; Xie J; Jacobs C; Vanderwinden JM; Erneux C; Pirson I
J Cell Physiol; 2008 Jan; 214(1):260-72. PubMed ID: 17620296
[TBL] [Abstract][Full Text] [Related]
15.
Olufunmilayo EO; Holsinger RMD
Genes (Basel); 2023 Sep; 14(10):. PubMed ID: 37895194
[TBL] [Abstract][Full Text] [Related]
16. Reduced expression and activity of patient-derived SHIP1 phosphatase domain mutants.
Ehm P; Nelson N; Giehler S; Schaks M; Bettin B; Kirchmair J; Jücker M
Cell Signal; 2023 Jan; 101():110485. PubMed ID: 36208705
[TBL] [Abstract][Full Text] [Related]
17. Phosphoinositide 5-phosphatases SKIP and SHIP2 in ruffles, the endoplasmic reticulum and the nucleus: An update.
Ramos AR; Ghosh S; Suhel T; Chevalier C; Obeng EO; Fafilek B; Krejci P; Beck B; Erneux C
Adv Biol Regul; 2020 Jan; 75():100660. PubMed ID: 31628071
[TBL] [Abstract][Full Text] [Related]
18. PTEN and Other PtdIns(3,4,5)P
Csolle MP; Ooms LM; Papa A; Mitchell CA
Int J Mol Sci; 2020 Dec; 21(23):. PubMed ID: 33276499
[TBL] [Abstract][Full Text] [Related]
19. The role of the inositol polyphosphate 5-phosphatases in cellular function and human disease.
Ooms LM; Horan KA; Rahman P; Seaton G; Gurung R; Kethesparan DS; Mitchell CA
Biochem J; 2009 Apr; 419(1):29-49. PubMed ID: 19272022
[TBL] [Abstract][Full Text] [Related]
20. Comparative mechanistic and substrate specificity study of inositol polyphosphate 5-phosphatase Schizosaccharomyces pombe Synaptojanin and SHIP2.
Chi Y; Zhou B; Wang WQ; Chung SK; Kwon YU; Ahn YH; Chang YT; Tsujishita Y; Hurley JH; Zhang ZY
J Biol Chem; 2004 Oct; 279(43):44987-95. PubMed ID: 15316017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
